Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
palifermin
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)
Phase:
Phase III
Type:
Supportive care
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
20040212
, NCT00109031
2.
Palifermin After Haploidentical PBSCT
Phase:
Phase II
Type:
Treatment
Status:
Approved-not yet active
Age:
18 to 65
Sponsor:
Other
Protocol IDs:
EudraCt: 2007-003241-32
, NCT00570999
3.
Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
Phase:
Phase II
Type:
Supportive care, Treatment
Status:
Active
Age:
Under 65
Sponsor:
Other
Protocol IDs:
08-008
, NCT00629798
4.
A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
1 to 16
Sponsor:
Other
Protocol IDs:
20010133
, NCT00460421
5.
Phase I Pilot Study of High-Dose Melphalan and Palifermin in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation for Stage II or III Multiple Myeloma
Phase:
Phase I
Type:
Supportive care, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
WSU-2006-119
, WSU 2006-119, NCT00482846
6.
Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Phase:
Phase I
Type:
Supportive care
Status:
Active
Age:
2 to 18
Sponsor:
Other
Protocol IDs:
PALSCT
, NCT00701688
Select All on Page
Help with Results
